Sakado, Japan

Yuko Morioka

This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Japan Limited. Active years: 1992-1996.


% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Sakado, JP (1992)
  • Saitama, JP (1996)

Company Filing History:


Years Active: 1992-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuko Morioka: Innovator in Pharmaceutical Advancements

Introduction

Yuko Morioka is a prominent inventor based in Sakado, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bladder and peptic ulcer conditions. With a total of 2 patents, her work has the potential to improve the quality of life for many patients.

Latest Patents

Morioka's latest patents include a pharmaceutical composition aimed at increasing bladder capacity. This composition is designed to improve dysuria by utilizing a pharmaceutical carrier and a therapeutically effective amount of a xanthine derivative. The formulation is effective in prolonging urination intervals and increasing urination threshold pressure, with minimal impact on the bladder's constrictive force. Additionally, she has developed a method for treating peptic ulcer disease, which involves therapeutic agents containing specific compounds that target the condition effectively.

Career Highlights

Yuko Morioka is currently associated with Hoechst Japan Limited, where she continues to innovate in the pharmaceutical sector. Her research focuses on developing effective treatments that address common yet challenging health issues.

Collaborations

Morioka has collaborated with notable colleagues, including Toshizo Tanaka and Ulrich Gebert, to advance her research and patent applications.

Conclusion

Yuko Morioka's contributions to pharmaceutical innovations demonstrate her commitment to improving healthcare solutions. Her patents reflect her expertise and dedication to addressing critical medical needs.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…